BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25879364)

  • 1. Squamous carcinoma coexistent with teratoma of ovary: a clinicopathological study of 12 cases diagnosed over a 10-year period at a tertiary cancer referral center.
    Rekhi B; Parikh P; Deodhar KK; Menon S; Maheshwari A; Kerkar R; Gupta S
    J Cancer Res Ther; 2015; 11(1):211-5. PubMed ID: 25879364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Squamous cell carcinoma arising in mature cystic teratoma of the ovary.
    Tseng CJ; Chou HH; Huang KG; Chang TC; Liang CC; Lai CH; Soong YK; Hsueh S; Pao CC
    Gynecol Oncol; 1996 Dec; 63(3):364-70. PubMed ID: 8946873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamma mode of infiltration associated with poor prognosis in malignant teratoma of the ovary: A case report.
    Spannuth WA; Rocconi RP; Kirby TO; Huh WK; Conner MG
    Gynecol Oncol; 2005 Jul; 98(1):155-7. PubMed ID: 15922442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of combined use of macrophage colony-stimulating factor and squamous cell carcinoma antigen as a selective diagnostic marker for squamous cell carcinoma arising in mature cystic teratoma of the ovary.
    Suzuki M; Tamura N; Kobayashi H; Ohwada M; Terao T; Sato I
    Gynecol Oncol; 2000 Jun; 77(3):405-9. PubMed ID: 10831350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Squamous cell carcinoma arising in mature cystic teratoma of the ovary. Clinicopathologic and topographic analysis.
    Hirakawa T; Tsuneyoshi M; Enjoji M
    Am J Surg Pathol; 1989 May; 13(5):397-405. PubMed ID: 2712191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of squamous cell carcinoma antigen in squamous cell carcinoma arising in mature cystic teratoma of the ovary.
    Suzuki M; Kobayashi H; Sekiguchi I; Konnai K; Terao T; Sato I
    Oncology; 1995; 52(4):287-90. PubMed ID: 7777241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of mature teratomas containing malignant elements.
    Hirai K; Ishiko O; Itoh F; Nakagawa E; Kanaoka Y; Sumi T; Ogita S
    Oncol Rep; 2000; 7(3):655-7. PubMed ID: 10767385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant degeneration of a mature ovarian teratoma.
    Christopherson WA; Councell RB
    Int J Gynaecol Obstet; 1989 Dec; 30(4):379-84. PubMed ID: 2576549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transvaginal color Doppler ultrasonic characterization of benign and malignant ovarian cystic teratomas and comparison with serum squamous cell carcinoma antigen.
    Emoto M; Obama H; Horiuchi S; Miyakawa T; Kawarabayashi T
    Cancer; 2000 May; 88(10):2298-304. PubMed ID: 10820352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant transformation of ovarian mature cystic teratoma.
    Rim SY; Kim SM; Choi HS
    Int J Gynecol Cancer; 2006; 16(1):140-4. PubMed ID: 16445624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis of squamous cell carcinoma arising from mature cystic teratoma of the ovary.
    Kikkawa F; Nawa A; Tamakoshi K; Ishikawa H; Kuzuya K; Suganuma N; Hattori S; Furui K; Kawai M; Arii Y
    Cancer; 1998 Jun; 82(11):2249-55. PubMed ID: 9610706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical features and prognostic factors of malignant ovarian teratoma].
    Jin FM; Zhu GZ; Feng YJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):427-30. PubMed ID: 12974088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Characteristics of rare ovarian tumors--possibilities of organ preservation].
    Grischke EM; Wallwiener D; Bastert G
    Zentralbl Gynakol; 1996; 118(6):322-5. PubMed ID: 8768007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Squamous cell carcinoma arising from mature cystic teratoma of the ovary: a clinicopathologic analysis.
    Kikkawa F; Ishikawa H; Tamakoshi K; Nawa A; Suganuma N; Tomoda Y
    Obstet Gynecol; 1997 Jun; 89(6):1017-22. PubMed ID: 9170484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant degeneration of a mature cystic teratoma five decades after discovery.
    Griffiths D; Wass J; Look K; Sutton G
    Gynecol Oncol; 1995 Dec; 59(3):427-9. PubMed ID: 8522269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Squamous cell carcinoma in mature cystic teratoma in a young woman: a diagnostic and management dilemma.
    Comerci JT; Jones JG; Fields AL; Runowicz CD; Goldberg GL
    Eur J Gynaecol Oncol; 1996; 17(6):501-3. PubMed ID: 8971527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Squamous cell carcinoma arising from mature cystic teratoma: a report of three cases.
    Bontis J; Vakiani M; Vavilis D; Agorastos T; Dragoumis K
    Eur J Gynaecol Oncol; 1996; 17(1):49-52. PubMed ID: 8750515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immature teratoma of the ovary.
    Gershenson DM; del Junco G; Silva EG; Copeland LJ; Wharton JT; Rutledge FN
    Obstet Gynecol; 1986 Nov; 68(5):624-9. PubMed ID: 3763073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.